Carcinoma de paratiróide

Bibliographic Details
Main Author: Vieira, José Gilberto H. [UNIFESP]
Publication Date: 2005
Other Authors: Ohe, Monique Nakayama [UNIFESP], Hauache, Omar M., Oliveira, Ulisses Maia de [UNIFESP], Delana, Janaina Martins [UNIFESP], Gonçalves, André [UNIFESP], Lazaretti-Castro, Marise [UNIFESP]
Format: Article
Language: por
Source: Repositório Institucional da UNIFESP
Download full: http://dx.doi.org/10.1590/S0004-27302005000500023
http://repositorio.unifesp.br/handle/11600/2736
Summary: Parathyroid carcinoma is a rare condition, comprising less than 1% of the cases of primary hyperparathyroidism (PHP). Nonetheless, due to its aggressiveness, and having prognosis dependent on the precocity of diagnosis and radical therapeutic approach, it is paramount that the clinical suspicion be made before surgery. Clinical presentation is typical of severe PHP, with a parathyroid tumor >1.5cm, usually palpable. The pathologic features sometimes are difficult to characterize. Our experience with this condition (from 1983 to 2004) includes 7 cases, all symptomatic, hypercalcemic syndrome and bone disease present in most of them. In 6/7 the tumor was palpable, and in all the biochemical profile was compatible with severe PHP. Three patients died of complications of hypercalcemia. Recent findings point to a mutation on the gene HRPT2 as the molecular base for the development of this kind of tumor. The therapeutic approach is surgical and should include ipsilateral thyroidectomy and cervical exploration in order to find possible local metastasis. Post-surgical complications (mainly hypocalcemia) are proportional to the pre-existing metabolic alterations. The long-term prognosis depends upon the precocity of diagnosis, surgical success and control of hypercalcemia. New therapeutic approaches, based on bisphosphonates and calcimimetic drugs, as well as the possibility of genetic diagnosis, tend to ameliorate the prognosis of this severe affection.
id UFSP_8aa5d4e45ee4724c47a7b96272ca96ab
oai_identifier_str oai:repositorio.unifesp.br/:11600/2736
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Carcinoma de paratiróideParathyroid carcinomaParathyroid carcinomaPrimary hyperparathyroidismHypercalcemiaPTHCarcinoma de paratiróideHiperparatiroidismo primárioHipercalcemiaPTHParathyroid carcinoma is a rare condition, comprising less than 1% of the cases of primary hyperparathyroidism (PHP). Nonetheless, due to its aggressiveness, and having prognosis dependent on the precocity of diagnosis and radical therapeutic approach, it is paramount that the clinical suspicion be made before surgery. Clinical presentation is typical of severe PHP, with a parathyroid tumor >1.5cm, usually palpable. The pathologic features sometimes are difficult to characterize. Our experience with this condition (from 1983 to 2004) includes 7 cases, all symptomatic, hypercalcemic syndrome and bone disease present in most of them. In 6/7 the tumor was palpable, and in all the biochemical profile was compatible with severe PHP. Three patients died of complications of hypercalcemia. Recent findings point to a mutation on the gene HRPT2 as the molecular base for the development of this kind of tumor. The therapeutic approach is surgical and should include ipsilateral thyroidectomy and cervical exploration in order to find possible local metastasis. Post-surgical complications (mainly hypocalcemia) are proportional to the pre-existing metabolic alterations. The long-term prognosis depends upon the precocity of diagnosis, surgical success and control of hypercalcemia. New therapeutic approaches, based on bisphosphonates and calcimimetic drugs, as well as the possibility of genetic diagnosis, tend to ameliorate the prognosis of this severe affection.Carcinoma de paratiróide é uma condição rara, correspondendo na maior parte das casuísticas a menos de 1% dos casos de hiperparatiroidismo primário (HPP). No entanto, pela sua gravidade, e com o prognóstico dependente do diagnóstico precoce e de uma conduta agressiva, é fundamental que a suspeita clínica seja feita pré-operatoriamente. As características clínicas são compatíveis com um caso de HPP grave, sintomático, com tumor cervical >1,5cm, podendo ser palpável. A definição anátomo-patológica pode ser difícil em muitos casos. Nossa casuística (1983-2004) compreende 7 casos, todos sintomáticos, com síndrome hipercalcêmica e doença óssea presente na maioria. Em 6/7 o tumor era palpável, e todos apresentavam quadro bioquímico compatível. Três pacientes faleceram em quadro de hipercalcemia refratária. Dados recentes apontam para uma mutação no gene HRPT2 como base molecular para o desenvolvimento destes tumores. A conduta é cirúrgica e deve incluir hemitiroidectomia e exploração cervical ampliada, procurando focos metastáticos. O pós-operatório é compatível com a gravidade da alteração metabólica pré-existente, sendo comum a tendência a hipocalcemia. O prognóstico de longo prazo depende do diagnóstico precoce, do sucesso cirúrgico e do controle da hipercalcemia. Novas possibilidades terapêuticas, na forma de bisfosfonatos e drogas calcimiméticas, bem como a possibilidade de diagnóstico genético, tendem a melhorar o prognóstico desta grave condição.Escola Paulista de Medicina Serviço de Doenças Ósteo-MetabólicasInstituto FleuryUNIFESP, EPM, Serviço de Doenças Ósteo-MetabólicasSciELOSociedade Brasileira de Endocrinologia e MetabologiaUniversidade Federal de São Paulo (UNIFESP)Instituto FleuryVieira, José Gilberto H. [UNIFESP]Ohe, Monique Nakayama [UNIFESP]Hauache, Omar M.Oliveira, Ulisses Maia de [UNIFESP]Delana, Janaina Martins [UNIFESP]Gonçalves, André [UNIFESP]Lazaretti-Castro, Marise [UNIFESP]2015-06-14T13:31:47Z2015-06-14T13:31:47Z2005-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion811-815application/pdfhttp://dx.doi.org/10.1590/S0004-27302005000500023Arquivos Brasileiros de Endocrinologia & Metabologia. Sociedade Brasileira de Endocrinologia e Metabologia, v. 49, n. 5, p. 811-815, 2005.10.1590/S0004-27302005000500023S0004-27302005000500023.pdf0004-2730S0004-27302005000500023http://repositorio.unifesp.br/handle/11600/2736porArquivos Brasileiros de Endocrinologia & Metabologiainfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-05T14:35:04Zoai:repositorio.unifesp.br/:11600/2736Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-05T14:35:04Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Carcinoma de paratiróide
Parathyroid carcinoma
title Carcinoma de paratiróide
spellingShingle Carcinoma de paratiróide
Vieira, José Gilberto H. [UNIFESP]
Parathyroid carcinoma
Primary hyperparathyroidism
Hypercalcemia
PTH
Carcinoma de paratiróide
Hiperparatiroidismo primário
Hipercalcemia
PTH
title_short Carcinoma de paratiróide
title_full Carcinoma de paratiróide
title_fullStr Carcinoma de paratiróide
title_full_unstemmed Carcinoma de paratiróide
title_sort Carcinoma de paratiróide
author Vieira, José Gilberto H. [UNIFESP]
author_facet Vieira, José Gilberto H. [UNIFESP]
Ohe, Monique Nakayama [UNIFESP]
Hauache, Omar M.
Oliveira, Ulisses Maia de [UNIFESP]
Delana, Janaina Martins [UNIFESP]
Gonçalves, André [UNIFESP]
Lazaretti-Castro, Marise [UNIFESP]
author_role author
author2 Ohe, Monique Nakayama [UNIFESP]
Hauache, Omar M.
Oliveira, Ulisses Maia de [UNIFESP]
Delana, Janaina Martins [UNIFESP]
Gonçalves, André [UNIFESP]
Lazaretti-Castro, Marise [UNIFESP]
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
Instituto Fleury
dc.contributor.author.fl_str_mv Vieira, José Gilberto H. [UNIFESP]
Ohe, Monique Nakayama [UNIFESP]
Hauache, Omar M.
Oliveira, Ulisses Maia de [UNIFESP]
Delana, Janaina Martins [UNIFESP]
Gonçalves, André [UNIFESP]
Lazaretti-Castro, Marise [UNIFESP]
dc.subject.por.fl_str_mv Parathyroid carcinoma
Primary hyperparathyroidism
Hypercalcemia
PTH
Carcinoma de paratiróide
Hiperparatiroidismo primário
Hipercalcemia
PTH
topic Parathyroid carcinoma
Primary hyperparathyroidism
Hypercalcemia
PTH
Carcinoma de paratiróide
Hiperparatiroidismo primário
Hipercalcemia
PTH
description Parathyroid carcinoma is a rare condition, comprising less than 1% of the cases of primary hyperparathyroidism (PHP). Nonetheless, due to its aggressiveness, and having prognosis dependent on the precocity of diagnosis and radical therapeutic approach, it is paramount that the clinical suspicion be made before surgery. Clinical presentation is typical of severe PHP, with a parathyroid tumor >1.5cm, usually palpable. The pathologic features sometimes are difficult to characterize. Our experience with this condition (from 1983 to 2004) includes 7 cases, all symptomatic, hypercalcemic syndrome and bone disease present in most of them. In 6/7 the tumor was palpable, and in all the biochemical profile was compatible with severe PHP. Three patients died of complications of hypercalcemia. Recent findings point to a mutation on the gene HRPT2 as the molecular base for the development of this kind of tumor. The therapeutic approach is surgical and should include ipsilateral thyroidectomy and cervical exploration in order to find possible local metastasis. Post-surgical complications (mainly hypocalcemia) are proportional to the pre-existing metabolic alterations. The long-term prognosis depends upon the precocity of diagnosis, surgical success and control of hypercalcemia. New therapeutic approaches, based on bisphosphonates and calcimimetic drugs, as well as the possibility of genetic diagnosis, tend to ameliorate the prognosis of this severe affection.
publishDate 2005
dc.date.none.fl_str_mv 2005-10-01
2015-06-14T13:31:47Z
2015-06-14T13:31:47Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1590/S0004-27302005000500023
Arquivos Brasileiros de Endocrinologia & Metabologia. Sociedade Brasileira de Endocrinologia e Metabologia, v. 49, n. 5, p. 811-815, 2005.
10.1590/S0004-27302005000500023
S0004-27302005000500023.pdf
0004-2730
S0004-27302005000500023
http://repositorio.unifesp.br/handle/11600/2736
url http://dx.doi.org/10.1590/S0004-27302005000500023
http://repositorio.unifesp.br/handle/11600/2736
identifier_str_mv Arquivos Brasileiros de Endocrinologia & Metabologia. Sociedade Brasileira de Endocrinologia e Metabologia, v. 49, n. 5, p. 811-815, 2005.
10.1590/S0004-27302005000500023
S0004-27302005000500023.pdf
0004-2730
S0004-27302005000500023
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv Arquivos Brasileiros de Endocrinologia & Metabologia
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 811-815
application/pdf
dc.publisher.none.fl_str_mv Sociedade Brasileira de Endocrinologia e Metabologia
publisher.none.fl_str_mv Sociedade Brasileira de Endocrinologia e Metabologia
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1841453702167134208